Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study.
Prince HM, Millward MJ, Rischin D, Blakey D, Francis P, Gates P, Chapple P, Quinn M, Juneja S, Wolf M, Januszewicz EH, Seymour JF, Brettell M, Strickland A, Zalcberg J, Richardson G, Scarlett J, Briggs P, Toner GC.
Prince HM, et al. Among authors: zalcberg j.
Ann Oncol. 1999 Apr;10(4):479-81. doi: 10.1023/a:1008317205955.
Ann Oncol. 1999.
PMID: 10370794
Free article.
Clinical Trial.